Insights

Field notes from the front line of quality.

Practical guidance from Globiox SMEs — FDA readiness, auditing, CAPA, validation, and quality systems for regulated life sciences.

Auditing

Step-by-Step Strategies for Effective REMS Audit Preparation

Written by: Patti Rossman Preparing for a REMS (Risk Evaluation and Mitigation Strategies) audit can be a daunting task, but with the right approach, it can be…

June 27, 2024
Quality & Validation

Staying Ahead: Navigating Timely Training and Version Control in Pharmaceuticals and Medical Devices

written by: Jenny Azarh In the dynamic world of Pharmaceuticals and Medical Devices, maintaining regulatory compliance and ensuring the highest standards of…

March 13, 2024
Company News & Events

Event: Register Today for ‘Building a Medical Device Quality Management System with Limited Resources’

Make the most out of BioFest Days and join us for an enlightening session hosted by Globiox, where seasoned subject matter experts (SMEs) share their wealth of…

March 4, 2024
Company News & Events

Globiox Stands Up and Stands Out at BioFest Invest

Globiox, a premier quality assurance firm, takes the stage as a presenting sponsor of Biofest Invest, reaffirming its commitment to innovation, growth, and…

February 19, 2024
Quality & Validation

Choosing the Right EQMS: Key Considerations in Quality Management System Selection

Written by: Steve Norris The terms “enterprise quality management system” (EQMS) and “electronic quality management system”(eQMS) are often used…

January 31, 2024
Company News & Events

Cultivating Peace and Harmony: Celebrating a Year of Impact in Life Science

As we approach the end of this remarkable year, we’d like to take a moment to express our heartfelt appreciation for the journey we’ve shared with our…

December 19, 2023
Company News & Events

Globiox Launches Free Consultations

We are proud to announce our launch of virtual office hours for 2021. Meeting with a Globiox subject matter expert has never been more simple. If you have…

May 21, 2021
FDA & Compliance

FDA’s Data Integrity citation trends of Biological Products

During the 2016-2018 period, the FDA performed routine inspections of the Biologics and Human Cellular and Tissue Products (HCT/P) facilities in the US and…

March 25, 2020
Company News & Events

September Office Hours At The University of Texas Dell Medical School CoLab

We are now offering office hours at The University of Texas Health CoLab to meet with aspiring life science companies for 1 hour consultations (FREE) regarding…

September 11, 2019
Medical Devices

Challenges of the Medical Device Market for New Manufacturers

Written by: Andrey Grishin, MD, Globiox Consultant Ensuring Quality of the Final Product. Every Medical device manufacturer must guaranty high product quality…

September 10, 2019
Company News & Events

FULL – Globiox’s office hours at The University of Texas Dell Medical School CoLab

All sessions are now FULL for Globiox’s office hours at the Texas Health CoLabs on August 15th and 16th, 2019. Check back in September for extended hours…

August 14, 2019
Company News & Events

Globiox’s Office Hours at The University of Texas Health CoLab

Globiox is excited to announce office hours at The University of Texas Health CoLab to meet with aspiring life science companies for 1 hour consultations…

August 12, 2019
FDA & Compliance

Latest Updates on Regulatory

Editor’s note (August 2026): On February 2, 2026, FDA’s Quality Management System Regulation (QMSR) replaced the Quality System Regulation, incorporating ISO…

July 30, 2019
Medical Devices

Clinical Evaluation Reports (CER) –

Written by: Daniel Miranda, Globiox Consultant Clinical evaluation is a critical, ongoing task that must be performed by medical device manufacturers who…

May 30, 2019
Medical Devices

Almost There: Safety and Performance Pathway Option for 510(k) Submissions

Written by: Daniel Miranda, Globiox Consultant On 1/22/2019, the FDA posted their final guidance describing the Safety and Performance Pathway option for…

February 18, 2019
Quality & Validation

Equipment validation is not process validation

Editor’s note (August 2026): On February 2, 2026, FDA’s Quality Management System Regulation (QMSR) replaced the Quality System Regulation, incorporating ISO…

June 11, 2014
FDA & Compliance

FDA plans major overhaul, looks to be more specialized

5 months ago the FDA announced that in response to “unparalleled challenges” posed by advances in science, globalization and product complexity, the agency…

February 12, 2014
Insights

We do what we do for a reason

There was a talk given at a recent conference by a man named Rick Roberts, who has been a victim of both drug shortages and counterfeit drugs. Mr. Roberts grew…

January 8, 2014
FDA & Compliance

CGMP now includes supply chain management

Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law on July 9, 2012 and addresses several areas, including the drug supply…

December 11, 2013
Auditing

The FDA’s “dos” and “don’ts” for responding to a 483

DO! • Include photos where possible. • Include documentation to provide evidence that corrective actions have been implemented. • Pay particular attention to…

November 13, 2013
Medical Devices

Design Control

Editor’s note (August 2026): On February 2, 2026, FDA’s Quality Management System Regulation (QMSR) replaced the Quality System Regulation, incorporating ISO…

August 14, 2013
Quality & Validation

High frequency of CAPA related observations in warning letters

Editor’s note (August 2026): On February 2, 2026, FDA’s Quality Management System Regulation (QMSR) replaced the Quality System Regulation, incorporating ISO…

July 18, 2013
Quality & Validation

Don’t let the user manual become the user

Over the years we have had many projects where users have asked us to qualify their laboratory equipment and validate commercial off-the-shelf (COTS) software…

June 12, 2013
FDA & Compliance

Combined use diagnostic instruments and the FDA’s thoughts

The FDA has recently released a draft guidance entitled “Molecular Diagnostic Instruments with Combined Functions.” The recommendations display intent to…

May 15, 2013
Quality & Validation

What happens when you can’t test a test?

Test Method Validation (TMV) is a critical part of ensuring quality for manufacturing. This highly specific aspect of validation involves proving that quality…

April 16, 2013
FDA & Compliance

Keeping up with the FDA

Quite a few companies in FDA regulated industries are experiencing “Dynamic Shock.” After handling their operations and quality assurance in the same manner…

December 11, 2012
FDA & Compliance

Warning Letters: What they are, How we can help

As discussed in our previous post, “FDA 483: your company contains critical errors,” a company whose operations are not compliant with the regulations set out…

October 9, 2012
Auditing

FDA 483: Does your business contain critical errors?

In the aftermath of an FDA site inspection resulting in unsatisfactory findings, the company in question faces a difficult situation that must be addressed…

August 22, 2012

Ready to get inspection-ready?

Request an Audit Quote
Globiox737.231.0233LinkedIn ↗TrackWise® is a registered trademark of Sparta Systems, Inc., a Honeywell company.Some illustrative imagery on this site is AI-generated.Payments are processed by Intuit Payments Inc. (NMLS #1098819).Privacy Policy · Terms of Service